Featured Posts
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Search Posts
News Release
Institute Condemns FDA Crackdown on Truthful Drug Advertising
The Competitive Enterprise Institute today condemned a recent Food and Drug Administration and Department of Justice crackdown on the dissemination by drug manufacturers of information…
Newsletter
Cybersecurity, Consumer Snitching and an Insurance Downgrade
A new bill to would give the White House “cybersecurity emergency” powers. Consumer Reports magazine turns a high-performing showerhead over to the EPA for exceeding…
Op-Eds
Obama Keeps Lying About Health Care, Even After Being Caught
You just can’t trust President Obama’s claims about his health-care plan. He keeps on lying even after he is caught lying and his lies…
Newsletter
Healthcare Complexity, Union Politics and Insurance Markets
Critics question the unwieldy complexity of current healthcare legislation. A compromise version of the so-called “Employee Free Choice Act” gains momentum in Congress. Florida Rep.
Newsletter
EPA’s Economists, Healthcare Rallies and the Cash for Clunkers Crash
Environmental Protection Agency officials consider scrapping the agency’s economics office after receiving a report critical of current global warming policy. Democrats plan public rallies to…
Comment
Comments on the FDA’s Draft Guidance for Industry, Presenting Risk Information In Prescription Drug and Medical Device Promotion
In comments on an FDA draft guidance document for drug industry advertising, CEI challenged the agency to bring its “1960s approach to prescription drug advertising…